Paid Clinical Trials in Stony Brook, NY
As of June 2026, 201 paid clinical trials are recruiting in Stony Brook, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Stony Brook offers studies at sites including Stony Brook University Medical Center for conditions such as Breast Cancer, Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Heart Failure. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Stony Brook
Trials by drug in Stony Brook
Filter results
201 clinical trials
↓ Download CSVA US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
First Responder Safety Training (FiRST)
SeeMe: Using Automated Facial Tracking to Detect Voluntary Behavior in Brain Injury
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy
Fear and Anxiety in Anesthesia-Naïve Patients Pre-operatively vs Post-operatively
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Definitive Radiation Therapy for Inoperable Breast Cancer
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
TaVNS for Delirium
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
The Role of mGluR5 in CBT-I
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
Postpartum Intervention for Mothers With Opioid Use Disorders (R33)
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
MMA Embolization for Refractory Chronic Migraine
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
The VENTOR Clinical Study
About research studies in Stony Brook
Stony Brook has approximately 201 recruiting research studies across a wide range of therapeutic areas. New York is home to leading academic medical centers such as Memorial Sloan Kettering, Weill Cornell Medicine, Mount Sinai, NYU Langone, and Columbia University Irving Medical Center. These institutions anchor a research ecosystem that covers oncology, cardiology, neurology, and rare disease.
Top Research Study Locations in Stony Brook
Researchers run research studies in Stony Brook, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Stony Brook University Medical Center | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Acute Myeloid Leukemia Post Cytotoxic Therapy | 69 |
| Stony Brook University Hospital | Intracerebral Hemorrhage, Aneurysm, Intracranial, Anxiety | 36 |
| Stony Brook University | Cancer, Opioid Use Disorder, Advanced Cancer | 17 |
| Stony Brook Medicine | Focal Epilepsy, Hypertension, Abdominal Aortic Aneurysm | 14 |
| Stony Brook University Cancer Center | Breast Cancer, Advanced Melanoma, Breast Adenocarcinoma | 8 |
| Stony Brook Cancer Center | Acute Myeloid Leukemia, AML, AML With Mutated NPM1 | 6 |
| Stony Brook University-Cancer Center | Breast Neoplasms, Non Small Cell Lung Cancer, Non-small Cell Lung Cancer | 3 |
| Local Institution - 1034 | Psychosis Associated With Alzheimer's Disease | 2 |
| Nkarta Investigational Site | Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, Idiopathic Inflammatory Myopathies, Lupus Nephritis | 2 |
| Stony Brook Children's Hospital | Congenital CMV Infection, Failed or Difficult Intubation, Sequela, Intubation Complication | 2 |
| Stony Brook University: Dept of Psychiatry | Major Depressive Disorder (MDD) | 2 |
| 5040, SUNY Stony Brook Clinical Research Site | HIV Infection | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Ascentage Investigative | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL | 1 |
| Elyse S. Rafal, MD PC - Rafal Center for Dermatology & Cosmetic Surgery | Plaque Psoriasis | 1 |
| GSK Investigational Site | Multiple Myeloma, Newly Diagnosed Multiple Myeloma | 1 |
| Investigative | Hidradenitis Suppurativa (HS) | 1 |
| Laufer Center for Physical and Quantitative Biology , Stony Brook University | Bipolar Disorder, Bipolar Disorder Type 1 | 1 |
| Local Institution - 0111 | Lupus Erythematosus, Systemic, Lupus Nephritis | 1 |
| Local Institution - 0221 | Relapsed or Refractory Multiple Myeloma (RRMM) | 1 |
| Renaissance School of Medicine Stony Brook University | Cesarean Delivery, General Anesthesia | 1 |
| SUNY Stony Brook | Hepatitis C | 1 |
| Site 5040, SUNY Stony Brook NICHD CRS | Pregnancy | 1 |
| Stony Brook | Vein Disease, Vein Occlusion, Vein Thrombosis | 1 |
| Stony Brook Advanced Specialty Care | Interstitial Lung Disease, Progressive Pulmonary Fibrosis | 1 |
Active & Upcoming Studies in Stony Brook (2026)
Recruiting trials in Stony Brook grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (104 active studies)
- Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer · Phase 3 · National Cancer Institute (NCI)
- Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer · Phase 3 · Canadian Cancer Trials Group
Cardiovascular (15 active studies)
- Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) · Phase 3 · Reprieve Cardiovascular, Inc
- The VENTOR Clinical Study · CoLabs Medical
Neurology & pain (10 active studies)
- The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms · phenox Inc.
- MMA Embolization for Refractory Chronic Migraine · Cerenovus, Part of DePuy Synthes Products, Inc.
Mental health & behavior (4 active studies)
- Fear and Anxiety in Anesthesia-Naïve Patients Pre-operatively vs Post-operatively · Stony Brook University
- Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder · Stony Brook University
HIV / STI (2 active studies)
- Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV · Phase 1, Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)
- Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission · Phase 1, Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)
Vaccines (1 active study)
Pediatric (1 active study)
- Monetary Incentive Delay Task for Probing Reward-related Neural Processes · Stony Brook University
Common conditions studied in Stony Brook
- Breast Cancer (11 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Acute Myeloid Leukemia (10 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Heart Failure (4 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Acute Myeloid Leukemia Post Cytotoxic Therapy (3 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- B Acute Lymphoblastic Leukemia (3 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
Leading research sponsors in Stony Brook
- Stony Brook University
- National Cancer Institute (NCI)
- Children's Oncology Group
- AstraZeneca
- NRG Oncology
Local regulations and guidelines
Clinical trials in New York are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials conducted in New York must also comply with the NY SHIELD Act's data-protection requirements and additional oversight from the New York State Department of Health.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Stony Brook. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Stony Brook
Hipa.ai aggregates every recruiting study in Stony Brook from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Stony Brook?
There are approximately 201 recruiting clinical trials in Stony Brook, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Stony Brook pay participants?
Most recruiting trials in Stony Brook compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Stony Brook?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Stony Brook?
The most common conditions under active study in Stony Brook include Breast Cancer (11), Acute Myeloid Leukemia (10), Anatomic Stage II Breast Cancer AJCC v8 (4), Heart Failure (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Stony Brook?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Stony Brook on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Stony Brook?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Stony Brook?
Recruiting research sites in Stony Brook include Stony Brook University Medical Center, Stony Brook University Hospital, Stony Brook University, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Stony Brook right now?
The largest active categories in Stony Brook are Cancer & tumors (104), Cardiovascular (15), Neurology & pain (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.